-
Chandra Bhagat Pharma Gets US FDA Approval for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate Nasal Spray, 50 mcg
Chandra Bhagat Pharma Limited (CBPL), a leading pharmaceutical company in India, today announced that it has received final approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate Nasal Spray, 50 mcg.
-
Chandra Bhagat Pharma Clocks Strong Growth in Q3FY23
Chandra Bhagat Pharma Limited (CBPL), a leading manufacturer of pharmaceutical formulations, has announced strong growth in its financial results for the third quarter ended December 31, 2022 (Q3FY23).
-
Chandra Bhagat Pharma Expands Manufacturing Capacity
Chandra Bhagat Pharma Limited (CBPL) has announced plans to expand its manufacturing capacity by setting up a new state-of-the-art facility in Baddi, Himachal Pradesh.
-
Chandra Bhagat Pharma Launches New Range of Antibiotic Products
Chandra Bhagat Pharma Limited (CBPL) has launched a new range of antibiotic products under the brand name 'Antibio-Pro'. The range includes a wide spectrum of antibiotics to treat various bacterial infections.
-
Chandra Bhagat Pharma Limited Announces Collaboration with Leading Pharmaceutical Company
Chandra Bhagat Pharma Limited (CBPL), a leading pharmaceutical company in India, today announced a collaboration with [Pharmaceutical Company Name], a global leader in the development and manufacturing of innovative medicines. This strategic partnership will combine CBPL's strong presence in the Indian market with [Pharmaceutical Company Name]'s expertise in research and development to bring new and improved treatments to patients in India.
-
Chandra Bhagat Pharma Limited Launches New Manufacturing Facility in Maharashtra
Chandra Bhagat Pharma Limited (CBPL) has announced the launch of its new state-of-the-art manufacturing facility in Maharashtra. The new facility will enable CBPL to expand its production capacity and meet the growing demand for its products in India and abroad. The facility is equipped with advanced technology and equipment, and it complies with all applicable regulatory standards.
-
Chandra Bhagat Pharma Limited Receives Prestigious Industry Award
Chandra Bhagat Pharma Limited (CBPL) has been honored with the prestigious [Award Name] at the [Event Name] held recently. This award recognizes CBPL's commitment to innovation, quality, and customer satisfaction in the pharmaceutical industry.
-
Chandra Bhagat Pharma Appoints Venkat Pillalamarri as New Head of Commercial Operations
Chandra Bhagat Pharma Limited, a fast-growing pharmaceutical company based in Hyderabad, India, has appointed Venkat Pillalamarri as its new Head of Commercial Operations. In this role, Venkat will be responsible for leading and executing the company's commercial strategy, including sales, marketing, and business development.
-
Chandra Bhagat Pharma Reports Strong Financial Results for Q3 FY23
Chandra Bhagat Pharma Limited, a leading pharmaceutical company based in Hyderabad, India, has reported strong financial results for the third quarter of fiscal year 2023 (Q3 FY23). The company's revenue grew by 15% year-over-year, driven by strong demand for its products in both domestic and international markets.
-
Chandra Bhagat Pharma Launches New Manufacturing Facility in Hyderabad
Chandra Bhagat Pharma Limited, a leading pharmaceutical company based in Hyderabad, India, has launched a new state-of-the-art manufacturing facility in Hyderabad. The new facility will produce a range of pharmaceutical products, including generic drugs, active pharmaceutical ingredients (APIs), and specialty products.
-
Chandra Bhagat Pharma Announces Acquisition of New Manufacturing Facility
The company has acquired a new manufacturing facility in Hyderabad, India to expand its production capacity and enhance its portfolio of products.
-
Chandra Bhagat Pharma Launches New Drug for Chronic Kidney Disease
The company has launched a new drug under the brand name 'Nephrocare' for the treatment of chronic kidney disease, offering patients a safe and effective treatment option.
-
Chandra Bhagat Pharma Collaborates with Global Healthcare Company
The company has entered into a strategic collaboration with a leading global healthcare company to develop and commercialize innovative therapies for cancer treatment.